HGI-001 Injection

DRUG2 trials

Sponsors

Prince of Wales Hospital, Shatin, Hong Kong, Hemogen HongKong Alpha Technology, Ltd

Conditions

Beta Thalassemia Transfusion DependentPatients with transfusion-dependent beta-thalassemia (TDT) Thalassemia

Phase 1

An Open Label Study Evaluating the Safety and Efficacy of HGI-001 Injection in Patients with Transfusion-Dependent Beta-Thalassemia

Active, not recruitingTCTR20241029003

Hemogen HongKong Alpha Technology, LtdPatients with transfusion-dependent beta-thalassemia (TDT) Thalassemia

Start: 2025-01-01Target: 2Updated: 2026-08-03

Phase 2

Gene Therapy for Patients With Transfusion-Dependent β-Thalassemia

Not yet recruitingNCT07721480

Prince of Wales Hospital, Shatin, Hong KongBeta Thalassemia Transfusion Dependent

Start: 2026-09-01End: 2030-12-01Target: 6Updated: 2026-07-23